Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mungall

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Idrugs : the Investigational Drugs Journal|August 30, 2005
Desmin 370 (Opocrin SpA/Alfa Wassermann)D Mungall
Archives of Internal Medicine|June 13, 1998
Activated partial thromboplastin time vs heparin concentrationD Mungall
Journal of Clinical Pharmacology|November 1, 1989
Bayesian forecasting of APTT response to continuously infused heparin with and without warfarin administrationD Mungall, R Floyd
Annals of Internal Medicine|November 15, 1992
Aging and warfarin therapyD Mungall, R White
Therapeutic Drug Monitoring|January 1, 1991
Outpatient management of warfarin therapy: comparison of computer-predicted dosage adjustment to skilled professional careR H White, D Mungall
Computers and Biomedical Research, an International Journal|February 1, 1982
Computer-assisted oral and intravenous theophylline therapyD Mungall, W Bancroft, J Marshall
The Annals of Pharmacotherapy|November 1, 1994
Comment: Heparin infusion ratesJ Slywka, D Mungall, T Luoma
Therapeutic Drug Monitoring|May 1, 1990
Predicting the daily prothrombin time response to warfarinL Farrow, D Mungall, G Raskob, et al.
Therapeutic Drug Monitoring|January 1, 1981
Quantitation of plasma warfarin concentrations by high performance liquid chormatographyC A Robinson, D Mungall, M C Poon
Therapeutic Drug Monitoring|September 1, 1991
Predicting pharmacodynamic response to tissue plasminogen activator: a preliminary reportD Mungall, R S Porter, E J Reisdorf
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Idrugs : the Investigational Drugs Journal|August 30, 2005
Desmin 370 (Opocrin SpA/Alfa Wassermann)D Mungall
Archives of Internal Medicine|June 13, 1998
Activated partial thromboplastin time vs heparin concentrationD Mungall
Journal of Clinical Pharmacology|November 1, 1989
Bayesian forecasting of APTT response to continuously infused heparin with and without warfarin administrationD Mungall, R Floyd
Annals of Internal Medicine|November 15, 1992
Aging and warfarin therapyD Mungall, R White
Therapeutic Drug Monitoring|January 1, 1991
Outpatient management of warfarin therapy: comparison of computer-predicted dosage adjustment to skilled professional careR H White, D Mungall
Computers and Biomedical Research, an International Journal|February 1, 1982
Computer-assisted oral and intravenous theophylline therapyD Mungall, W Bancroft, J Marshall
The Annals of Pharmacotherapy|November 1, 1994
Comment: Heparin infusion ratesJ Slywka, D Mungall, T Luoma
Therapeutic Drug Monitoring|May 1, 1990
Predicting the daily prothrombin time response to warfarinL Farrow, D Mungall, G Raskob, et al.
Therapeutic Drug Monitoring|January 1, 1981
Quantitation of plasma warfarin concentrations by high performance liquid chormatographyC A Robinson, D Mungall, M C Poon
Therapeutic Drug Monitoring|September 1, 1991
Predicting pharmacodynamic response to tissue plasminogen activator: a preliminary reportD Mungall, R S Porter, E J Reisdorf
Pageof 3